openPR Logo
Press release

Global Migraine Drugs Market (2018-2025)-GMI Research

09-19-2018 05:13 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: GMI Research

Global Migraine Drugs Market (2018-2025)-GMI Research

Global Migraine Drugs Market (2018-2025)-GMI Research

Global Migraine Drugs Market by Drug Type (Abortive Drugs and Preventive Drugs), by Route of Administration (Oral, Injectables and Others), End User (Hospital Pharmacies, Retail Pharmacies and Others), and by Geography – Opportunities & Forecast, 2018-2025

Migraine is a neurological disorder that causes severe pain in head and results in nausea, vomiting, and extreme sensitivity to light and sound. The common types of migraine are with aura and without aura that means classical migraines and common migraines.

Download Sample Brochure : https://www.gmiresearch.com/sample-research-report.php?rid=132

According to migraine trust website, in 2016, migraine headaches affected about 12.0% to 14.7% of population across the globe. Migraine has been categorized by frequency and nature of attack into episodic migraine and chronic migraine as per international as well regional guidelines. Migraine is an extraordinarily prevalent neurological disease, affecting 39 million men, women and children in the US and 1 billion worldwide. As per World Health Organization (WHO) in 2016, about 50% of migraine disorders were reported, out of which, women patients were more.

Rise in prevalence of migraine in the age group of 30 to 40 drives the migraine drugs market. Moreover, increase in female population and surge in awareness among patients related to prevention and treatment of migraine are the key factors that augment the growth of the market. However, side effects like fatigue, nausea, lowering of blood pressure, etc., associated with migraine drugs is a factor that hinders the market growth. Migraine disorders are among the most common disorders of the nervous system, mostly observed in adult population. Furthermore, North America holds the largest share in the migraine drugs market as it has large number of ageing population.

Various notable players operating in the global migraine drugs market include Abbott Laboratories, Aegis Therapeutics, LLC, Aerial Biopharma LLC, Alder Biopharmaceuticals Inc., Amgen Inc, Astellas Pharma, AstraZeneca, Johnsons and Johnsons, Eisai Co Ltd, Eli Lily & Co and others.

The global migraine drugs market has been segmented on the basis of drug type, route of administration, end user and key geographies. Based on the drug type, the market comprises of abortive drugs and preventive drugs. Based on route of administration, the market is classified into Oral, Injectables and Others. Based on end user market is segmented into Hospital pharmacies, retail pharmacies and others.

This research report “global migraine drugs market” provides in-depth analysis of the migraine drugs market across the globe based on drug type, route of administration, end user and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for migraine drugs market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1- At what pace is migraine drugs market growing worldwide? What will be growth trend in future?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the migraine drugs market?
4- What are the various application areas and how they are poised to grow?

The global migraine drugs market has been segmented based on drug type, route of administration, end user and geography:

Global Migraine Drugs Market, by Drug Type
• Abortive Drugs
• Preventive Drugs

Global Migraine Drugs Market, by Route of Administration
• Oral
• Injectables
• Others (Nasal Spray, Transdermal Path, etc.)

Global Migraine Drugs Market, by End User
• Hospitals Pharmacies
• Retail Pharmacies
• Others

Global Migraine Drugs Market, by Geography
• North America
As a part of customization
o By Drug Type
o By Route of Administration
o By End User
o United States
o Canada
o Mexico

• Europe
As a part of customization
o By Drug Type
o By Route of Administration
o By End User
o United Kingdom
o Germany
o Spain
o Rest of Europe

• Asia-Pacific
As a part of customization
o By Drug Type
o By Route of Administration
o By End User
o China
o Japan
o India
o Rest of Asia-Pacific

• Rest of the World
As a part of customization
o By Drug Type
o By Route of Administration
o By End User
o Brazil
o GCC countries
o South Africa
o Rest of ROW

Global Migraine Drugs Market Competitive Landscape

• Major Players and their Key Strategies
• New Drug Launches
• Mergers and Acquisitions
• Collaborations, Partnerships, Agreements and Joint Ventures

Leading Market Players
• Abbott Laboratories
• Aegis Therapeutics, LLC
• Aerial Biopharma LLC
• Alder Biopharmaceuticals Inc.,
• Amgen Inc Lucibel SA
• Astellas Pharma.
• AstraZeneca Velmenni OÜ
• Johnsons and Johnsons
• Eisai Co Ltd
• Eli Lily & Co
Other prominent players in the market which can be profiled as a part of customization:
• Teva Pharmaceutical Industries Ltd.
• GlaxoSmithKline plc
• Novartis AG
• Merck & Co., Inc.,

BUY Premuim Report : https://www.gmiresearch.com/buy-research-report.php?rid=132&licence=singaluser

Table of Contents (TOC)

• Executive Summary

• Introduction
• Study Objectives
• Market Definition
• Market Covered
• Geographical Coverage
• Study Years & Currency
• Market Stakeholders
• Key Questions this Study will Answer
• GMI Research’s Approach & Methodology

• Global Migraine Drugs Market- Overview
• Introduction `
• Market Segmentation
• Value Chain Analysis
• Drivers
• Restraints
• Trends

• Global Migraine Drugs Market Revenue Forecast till 2025

• Global Migraine Drugs Market by Drugs Type Revenue Forecast till 2025
• Abortive Drugs
• Preventive Drugs

• Global Migraine Drugs Market by Route of Administration Revenue Forecast till 2025
• Oral
• Injectables
• Others (Nasal Spray, Transdermal Path, etc.)

• Global Migraine Drugs Market by End User Revenue Forecast till 2025
• Hospitals Pharmacies
• Retail Pharmacies
• Others

• Global Migraine Drugs Market by Geography Revenue Forecast till 2025

• North America Migraine Drugs Market Revenue Forecast till 2025
• North America Migraine Drugs Market by Drug Type (Option 1: 25% customization)
• Abortive Drugs
• Preventive Drugs
• North America Migraine Drugs Market by Route of Administration
• Oral
• Injectables
• Others (Nasal Spray, Transdermal Path, etc.)
• North America Migraine Drugs Market by End User
• Hospitals
• Homecare Setting
• Others

• Europe Migraine Drugs Market Revenue Forecast till 2025
• Europe Migraine Drugs Market by Drug Type (Option 1: 25% customization)
• Abortive Drugs
• Preventive Drugs
• Europe Migraine Drugs Market by Route of Administration
• Oral
• Injectables
• Others (Nasal Spray, Transdermal Path, etc.)
• Europe Migraine Drugs Market by End User
• Hospitals
• Homecare Setting
• Others

• Asia-Pacific Migraine Drugs Revenue Forecast till 2025
• Asia-Pacific Migraine Drugs Market by Drug Type (Option 1: 25% customization)
• Abortive Drugs
• Preventive Drugs

• Asia- Pacific Migraine Drugs Market by Route of Administration
• Oral
• Injectables
• Others (Nasal Spray, Transdermal Path, etc.)
• Asia-Pacific Migraine Drugs Market by End User
• Hospitals
• Homecare Setting
• Others
• Rest of the World Migraine Drugs Market Revenue Forecast till 2025
• Rest of the World Migraine Drugs Market by Drug Type (Option 1: 25% customization)
• Abortive Drugs
• Preventive Drugs
• Rest of the World Migraine Drugs Market by Route of Administration
• Oral
• Injectables
• Others (Nasal Spray, Transdermal Path, etc.)
• Rest of the World Migraine Drugs Market by End User
• Hospitals
• Homecare Setting
• Others

• Competitive Landscape
• Industry Attractiveness
• Porter 5 Analysis
• Major players and their key strategies
• Company Share Analysis

• Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice)
• Abbott Laboratories
• Company Overview
• Financials
• Recent Developments
• Aegis Therapeutics
• Company Overview
• Financials
• Recent Developments
• Aerial Biopharma LLC
• Company Overview
• Financials
• Recent Developments
• Alder Biopharmaceuticals Inc
• Company Overview
• Financials
• Recent Developments
• Amgen Inc
• Company Overview
• Financials
• Recent Developments
• Astellas Pharma India Private Limited
• Company Overview
• Financials
• Recent Developments
• AstraZeneca
• Company Overview
• Financials
• Recent Developments
• Johnsons and Johnsons Services Inc
• Company Overview
• Financials
• Recent Developments
• Eisai Co Ltd.
• Company Overview
• Financials
• Recent Developments
• Eli Lily & Co
• Company Overview
• Financials
• Recent Developments

• About GMI Research

For Sample Pages & Detailed Report Description Visit : https://www.gmiresearch.com/report/global-migraine-drugs-market-opportunities-forecast-share-trends-insights.html

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: sales@gmiresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Migraine Drugs Market (2018-2025)-GMI Research here

News-ID: 1248384 • Views: 297

More Releases from GMI Research

Telecom Cloud Market earned USD 19.1 Billion in 2020 and anticipated to reach US …
Telecom Cloud Market reached USD 19.1 Billion in 2020 and is projected to reach USD 95.6 Billion in 2028, the market is growing at a CAGR of 22.3% till 2028. For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/telecom-cloud-market/ Key Drivers The factors proliferating the Telecom Cloud Market includes rising number of internet mobile subscriptions, inclination towards cloud computing services over land line services and growing demand for information infrastructure services. Increasing
Graphene Battery Market is estimated to reach USD 545 million in 2028, registeri …
Graphene Battery Market was valued at USD 73 million in 2020, and is estimated to reach USD 545 million in 2028, increasing at a higher CAGR of 28.5% during 2020-2028. For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/graphene-battery-market/ The factors driving the growth of Graphene Battery Market includes growing demand for graphene batteries in Automotive, consumer electronics and power sector, increasing investments on research and development for enhancing the lithium-ion
Social Media Analytics Market is estimated to touch USD 21.6 billion in 2029, re …
Social Media Analytics Market was valued at USD 4.2 billion in 2021 and is estimate to reach USD 21.6 billion in 2029 growing at a CAGR of 22.7% For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/social-media-analytics-market-analysis-industry-research/ The factors driving the growth of Social Media Analytics Market includes the increasing demand for business intelligence tools, increasing number of smartphones, growing focus by businesses on collecting customer feedback and proliferation of social
GCC Construction Chemical Market is Predicted to Expand at a Promising CAGR duri …
The GCC Construction Chemical Market is estimated to grow at a robust CAGR over the forecast period (2022-2029). For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/product/gcc-construction-chemical-market/ The factors driving growth of the GCC Construction Chemical Market includes increasing focus of Governments on reducing their dependency on oil and gas sector, emerging need to repair the ageing buildings, rise in the number of smart cities and improvements in the living standards.

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug